{"organizations": [], "uuid": "7f905552644f0d1ff02a7298609a7b31e9f45b5c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.reuters.com", "main_image": "https://s2.reutersmedia.net/resources/r/?d=20180129&i=OV805ZHJF&w=1200&r=OV805ZHJF&t=2", "site_section": "http://uk.reuters.com/rssVideo?videoChannel=5", "section_title": "Reuters Video: Business", "url": "https://uk.reuters.com/video/2018/01/29/biotech-ma-boom-sees-sanofi-snapping-up?videoId=389553878", "country": "US", "domain_rank": 408, "title": "Biotech M&A boom sees Sanofi snapping up Ablynx", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-29T18:07:00.000+02:00", "replies_count": 0, "uuid": "7f905552644f0d1ff02a7298609a7b31e9f45b5c"}, "author": "", "url": "https://uk.reuters.com/video/2018/01/29/biotech-ma-boom-sees-sanofi-snapping-up?videoId=389553878", "ord_in_thread": 0, "title": "Biotech M&A boom sees Sanofi snapping up Ablynx", "locations": [], "entities": {"persons": [{"name": "belgi", "sentiment": "negative"}, {"name": "amy pollock", "sentiment": "none"}], "locations": [], "organizations": [{"name": "sanofi", "sentiment": "negative"}, {"name": "ablynx biotech m&a", "sentiment": "negative"}, {"name": "novo nordisk", "sentiment": "none"}, {"name": "ablynx", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Biotech M&A boom sees Sanofi snapping up Ablynx Monday, January 29, 2018 - 01:01 \nFrench drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock reports.   \nFrench drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock reports.  //reut.rs/2nnhUyp", "external_links": [], "published": "2018-01-29T18:07:00.000+02:00", "crawled": "2018-01-30T07:48:29.026+02:00", "highlightTitle": ""}